Another study found that the nicotine treatment of a mouse model of AD (APPsw transgenic mice carrying the Swedish mutation in the human amyloid precursor protein) effectively reduced amyloid β-peptide aggregation in the brain, with a significant reduction of more than 80% in positive plaques in the brain [154]. This evidence concerns the gene APP and Alzheimer disease.